Crosstalk Between Endoplasmic Reticulum Stress and Multidrug-resistant Cancers: Hope or Frustration

Overview

Journal Front Pharmacol

Date 2023 Oct 4

PMID 37790807

Authors

Bowen Qing

Song Wang

Yingan Du

Can Liu

Wei Li

Affiliations

Soon will be listed here.

Abstract

Endoplasmic reticulum stress (ERS) is a kind of cell response for coping with hypoxia and other stresses. Pieces of evidence show that continuous stress can promote the occurrence, development, and drug resistance of tumors through the unfolded protein response. Therefore, the abnormal ac-tivation of ERS and its downstream signaling pathways not only can regulate tumor growth and metastasis but also profoundly affect the efficacy of antitumor therapy. Therefore, revealing the molecular mechanism of ERS may be expected to solve the problem of tumor multidrug resistance (MDR) and become a novel strategy for the treatment of refractory and recurrent tumors. This re-view summarized the mechanism of ERS and tumor MDR, reviewed the relationship between ERS and tumor MDR, introduced the research status of tumor tissue and ERS, and previewed the prospect of targeting ERS to improve the therapeutic effect of tumor MDR. This article aims to provide researchers and clinicians with new ideas and inspiration for basic antitumor treatment.

Citing Articles

Elucidation of anti-human melanoma and anti-aging mechanisms of compounds from green seaweed Caulerpa racemosa.

Wicaksono D, Taslim N, Lau V, Syahputra R, Alatas A, Putra P Sci Rep. 2024; 14(1):27534.

PMID: 39528552 PMC: 11555072. DOI: 10.1038/s41598-024-78464-6.

Subcellular Drug Distribution: Exploring Organelle-Specific Characteristics for Enhanced Therapeutic Efficacy.

Liu X, Li M, Woo S Pharmaceutics. 2024; 16(9).

PMID: 39339204 PMC: 11434838. DOI: 10.3390/pharmaceutics16091167.

17-AAG Induces Endoplasmic Reticulum Stress-mediated Apoptosis in Breast Cancer Cells, Possibly Through PERK/eIF2α Up-regulation.

Suwannalert P, Panpinyaporn P, Wantanachaisaeng P, Teeppaibul T, Worawichitchaikun T, Koomsang T In Vivo. 2024; 38(5):2228-2238.

PMID: 39187325 PMC: 11363749. DOI: 10.21873/invivo.13687.

The Cellular Stress and Cutaneous Manifestations in Renal Cell Carcinomas-A Narrative Review.

Ene C, Nicolae I, Tampa M, Georgescu S, Ene C, Matei C J Clin Med. 2024; 13(13).

PMID: 38999207 PMC: 11242689. DOI: 10.3390/jcm13133640.

References

Siebzehnrubl F, Silver D, Tugertimur B, Deleyrolle L, Siebzehnrubl D, Sarkisian M . The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance. EMBO Mol Med. 2013; 5(8):1196-212. PMC: 3944461. DOI: 10.1002/emmm.201302827. View

Wu T, Dai Y . Tumor microenvironment and therapeutic response. Cancer Lett. 2016; 387:61-68. DOI: 10.1016/j.canlet.2016.01.043. View

Grandjean J, Madhavan A, Cech L, Seguinot B, Paxman R, Smith E . Pharmacologic IRE1/XBP1s activation confers targeted ER proteostasis reprogramming. Nat Chem Biol. 2020; 16(10):1052-1061. PMC: 7502540. DOI: 10.1038/s41589-020-0584-z. View

Dekervel J, Bulle A, Windmolders P, Lambrechts D, Van Cutsem E, Verslype C . Acriflavine Inhibits Acquired Drug Resistance by Blocking the Epithelial-to-Mesenchymal Transition and the Unfolded Protein Response. Transl Oncol. 2016; 10(1):59-69. PMC: 5217771. DOI: 10.1016/j.tranon.2016.11.008. View

Chen J, Li Y, Yu T, McKay R, Burns D, Kernie S . A restricted cell population propagates glioblastoma growth after chemotherapy. Nature. 2012; 488(7412):522-6. PMC: 3427400. DOI: 10.1038/nature11287. View

Conner C, Lager T, Guldner I, Wu M, Hishida Y, Hishida T . Cell surface GRP78 promotes stemness in normal and neoplastic cells. Sci Rep. 2020; 10(1):3474. PMC: 7044190. DOI: 10.1038/s41598-020-60269-y. View

Li D, Wang W, Wang Y, Wang Y, Li Y . Lobaplatin promotes I-induced apoptosis and inhibition of proliferation in hepatocellular carcinoma by upregulating PERK-eIF2α-ATF4-CHOP pathway. Cell Death Dis. 2019; 10(10):744. PMC: 6776519. DOI: 10.1038/s41419-019-1918-1. View

Chen Y, Su J, Tsao C, Hung C, Chao H, Lin J . Sinulariolide induced hepatocellular carcinoma apoptosis through activation of mitochondrial-related apoptotic and PERK/eIF2α/ATF4/CHOP pathway. Molecules. 2013; 18(9):10146-61. PMC: 6270604. DOI: 10.3390/molecules180910146. View

Cao X, Hou J, An Q, Assaraf Y, Wang X . Towards the overcoming of anticancer drug resistance mediated by p53 mutations. Drug Resist Updat. 2019; 49:100671. DOI: 10.1016/j.drup.2019.100671. View

10.

Gorre M, Mohammed M, Ellwood K, Hsu N, Paquette R, Rao P . Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science. 2001; 293(5531):876-80. DOI: 10.1126/science.1062538. View

11.

Oskarsson T, Batlle E, Massague J . Metastatic stem cells: sources, niches, and vital pathways. Cell Stem Cell. 2014; 14(3):306-21. PMC: 3998185. DOI: 10.1016/j.stem.2014.02.002. View

12.

Tay K, Luan Q, Croft A, Jiang C, Jin L, Zhang X . Sustained IRE1 and ATF6 signaling is important for survival of melanoma cells undergoing ER stress. Cell Signal. 2013; 26(2):287-94. DOI: 10.1016/j.cellsig.2013.11.008. View

13.

Starck S, Tsai J, Chen K, Shodiya M, Wang L, Yahiro K . Translation from the 5' untranslated region shapes the integrated stress response. Science. 2016; 351(6272):aad3867. PMC: 4882168. DOI: 10.1126/science.aad3867. View

14.

Dong D, Dubeau L, Bading J, Nguyen K, Luna M, Yu H . Spontaneous and controllable activation of suicide gene expression driven by the stress-inducible grp78 promoter resulting in eradication of sizable human tumors. Hum Gene Ther. 2004; 15(6):553-61. DOI: 10.1089/104303404323142006. View

15.

Walcher L, Kistenmacher A, Suo H, Kitte R, Dluczek S, Strauss A . Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies. Front Immunol. 2020; 11:1280. PMC: 7426526. DOI: 10.3389/fimmu.2020.01280. View

16.

Salaroglio I, Panada E, Moiso E, Buondonno I, Provero P, Rubinstein M . PERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapy. Mol Cancer. 2017; 16(1):91. PMC: 5427528. DOI: 10.1186/s12943-017-0657-0. View

17.

Nie Z, Chen M, Gao Y, Huang D, Cao H, Peng Y . Ferroptosis and Tumor Drug Resistance: Current Status and Major Challenges. Front Pharmacol. 2022; 13:879317. PMC: 9163417. DOI: 10.3389/fphar.2022.879317. View

18.

Shi W, Chen Z, Li L, Liu H, Zhang R, Cheng Q . Unravel the molecular mechanism of XBP1 in regulating the biology of cancer cells. J Cancer. 2019; 10(9):2035-2046. PMC: 6548171. DOI: 10.7150/jca.29421. View

19.

Vitale I, Sistigu A, Manic G, Rudqvist N, Trajanoski Z, Galluzzi L . Mutational and Antigenic Landscape in Tumor Progression and Cancer Immunotherapy. Trends Cell Biol. 2019; 29(5):396-416. DOI: 10.1016/j.tcb.2019.01.003. View

20.

McGranahan N, Swanton C . Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future. Cell. 2017; 168(4):613-628. DOI: 10.1016/j.cell.2017.01.018. View